Filters
For individuals with dementia, statin use does not appear to provide cardioprotective benefits but rather contributes to an increased risk of hospitalization due to cardiovascular or cerebrovascular events, according to a retrospective study.
An association exists between hypertensive disorders of pregnancy (HDP) and adverse left ventricular (LV) remodelling, which is partially mediated by post-pregnancy BMI, suggests a study.
A systematic review and meta-analysis show an association between elevated salinity in drinking water and higher systolic blood pressure (SBP) and diastolic BP (DBP) levels, particularly among individuals residing in coastal areas.
Adults with elevated blood pressure (BP) who have better sleep efficiency tend to show lower short-term BP variability (BPV), reveals a study. However, longer sleep duration and perceived sleep quality appear to have no significant association with BPV.
The use of the 2022 ESC/ERC definitions of pulmonary arterial hypertension (PAH) has led to the identification of cirrhosis patients with early-stage portopulmonary hypertension (PoPH), who are at greater risk of death, reports a study.
Elevated concentrations of high-density lipoprotein cholesterol (HDL-C) are associated with favourable functional recovery in patients with ischaemic stroke, as suggested in a recent study.
A 19-year-old female university student with congenital heart disease–associated pulmonary arterial hypertension (PAH-CHD), who was on triple therapy and used home and portable oxygen, was referred to us for adult CHD management in July 2025. She had been referred earlier for lung transplantation due to severe PAH.
Middle aged or older people with an evening chronotype are at increased risk of cardiovascular disease (CVD), owing to their unfavourable cardiovascular health profile, according to a study.
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD), who also happen to have hypertension, are at much greater risk of adverse clinical outcomes and progression of liver stiffness and fibrosis, according to a study.
A pooled analysis of first-in-human and early feasibility studies demonstrates promising 30-day clinical and echocardiographic outcomes with the novel DurAVR transcatheter heart valve (THV) in patients with small aortic annuli (SAA).